Sign In
Buy OXSQ
Oxford Square Capital Earnings Calls
| Release date | Nov 04, 2025 |
| EPS estimate | $0.0700 |
| EPS actual | $0.0700 |
| Revenue estimate | 10.145M |
| Revenue actual | 1.656M |
| Revenue Surprise | -83.68% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0800 |
| Revenue estimate | 10M |
| Revenue actual | 7.201M |
| Revenue Surprise | -27.99% |
| Release date | Apr 25, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0900 |
| EPS Surprise | 12.50% |
| Revenue estimate | 10M |
| Revenue actual | -1997445 |
| Revenue Surprise | -119.97% |
| Release date | Feb 28, 2025 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0900 |
| EPS Surprise | 50.00% |
| Revenue estimate | 9.9M |
| Revenue actual | 4.311M |
| Revenue Surprise | -56.46% |
Last 4 Quarters for Oxford Square Capital
Below you can see how OXSQ performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 28, 2025 |
| Price on release | $2.81 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0900 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Feb 24, 2025 | $2.81 |
| Feb 25, 2025 | $2.76 |
| Feb 26, 2025 | $2.77 |
| Feb 27, 2025 | $2.80 |
| Feb 28, 2025 | $2.81 |
| Mar 03, 2025 | $2.84 |
| Mar 04, 2025 | $2.84 |
| Mar 05, 2025 | $2.79 |
| Mar 06, 2025 | $2.82 |
| 4 days before | 0% |
| 4 days after | 0.356% |
| On release day | 1.07% |
| Change in period | 0.356% |
| Release date | Apr 25, 2025 |
| Price on release | $2.55 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0900 |
| EPS surprise | 12.50% |
| Date | Price |
|---|---|
| Apr 21, 2025 | $2.42 |
| Apr 22, 2025 | $2.44 |
| Apr 23, 2025 | $2.44 |
| Apr 24, 2025 | $2.44 |
| Apr 25, 2025 | $2.55 |
| Apr 28, 2025 | $2.55 |
| Apr 29, 2025 | $2.55 |
| Apr 30, 2025 | $2.54 |
| May 01, 2025 | $2.54 |
| 4 days before | 5.37% |
| 4 days after | -0.392% |
| On release day | 0% |
| Change in period | 4.96% |
| Release date | Aug 07, 2025 |
| Price on release | $2.32 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0800 |
| Date | Price |
|---|---|
| Aug 01, 2025 | $2.30 |
| Aug 04, 2025 | $2.33 |
| Aug 05, 2025 | $2.35 |
| Aug 06, 2025 | $2.35 |
| Aug 07, 2025 | $2.32 |
| Aug 08, 2025 | $2.36 |
| Aug 11, 2025 | $2.37 |
| Aug 12, 2025 | $2.40 |
| Aug 13, 2025 | $2.37 |
| 4 days before | 0.87% |
| 4 days after | 2.16% |
| On release day | 1.72% |
| Change in period | 3.04% |
| Release date | Nov 04, 2025 |
| Price on release | $1.88 |
| EPS estimate | $0.0700 |
| EPS actual | $0.0700 |
| Date | Price |
|---|---|
| Oct 29, 2025 | $1.86 |
| Oct 30, 2025 | $1.83 |
| Oct 31, 2025 | $1.90 |
| Nov 03, 2025 | $1.89 |
| Nov 04, 2025 | $1.88 |
| Nov 05, 2025 | $1.92 |
| Nov 06, 2025 | $1.88 |
| Nov 07, 2025 | $1.91 |
| Nov 10, 2025 | $1.99 |
| 4 days before | 1.08% |
| 4 days after | 5.85% |
| On release day | 2.13% |
| Change in period | 6.99% |
Oxford Square Capital Earnings Call Transcript Summary of Q3 2025
Oxford Square reported Q3 2025 net investment income (NII) of ~$5.6 million ($0.07/share) and NAV of $1.95/share, down from $2.06 the prior quarter. Total investment income rose to ~$10.2 million, while combined unrealized and realized losses were ~$7.5 million for the quarter. The company distributed $0.105/share during the quarter and announced monthly distributions of $0.035/share for January–March 2026. Activity included ~$58.1 million of purchases, ~$31.3 million of repayments, ~$11.8 million net proceeds from an ATM issuance (≈5.4 million shares), issuance of $74.8 million of 7.75% unsecured notes due July 2030, and repayment of $34.8 million of 6.25% notes due April 2026. Portfolio actions emphasized purchases of long-dated CLO equity from top-tier managers and a mix of higher-quality leveraged loans and opportunistic, less-liquid secondary loans. Management noted the loan market remains reasonably stable, with modest price moves and elevated trailing default measures, and said CLO equity capacity is currently at its internal maximum unless the portfolio is rotated. Cash balances ticked up (~$51 million) largely due to ATM timing. Management highlighted that the portfolio is relatively lightly levered versus statutory limits and indicated leverage remains a lever to potentially improve NII going forward.
